Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
4
2022
Even Indirect Income from Cannabis Can Get You Banned From Bankruptcy Ward and Smith, P.A.
May
4
2022
Canada Publishes Dietary Guidelines Resource Keller and Heckman LLP
May
3
2022
Celebrity Collaborations Are All the Buzz: Six Key Considerations for Alcohol Beverage Brands and Celebrities ArentFox Schiff LLP
May
3
2022
Massachusetts for ARPA-H Mintz
May
3
2022
False Fruit Labeling Claim Moves Forward Keller and Heckman LLP
May
2
2022
Attorney General Garland Reconfirms the DOJ’s Hands-Off Approach Toward Federal Marijuana Prosecution
May
2
2022
OIG Says that Increasing Use of Biosimilars Could Reduce Part D Spending Mintz
May
2
2022
Litigation Minute: Defending Consumer Class Action Claims Involving PFAS K&L Gates
May
2
2022
New Draft Guidance on FDA’s Accredited Third-Party Certification Program Keller and Heckman LLP
May
1
2022
Northern District of Illinois Decisions Find Access or Disclosure Exclusion Precludes Coverage for BIPA Claims, Creating a New Split in the District Wilson Elser Moskowitz Edelman & Dicker LLP
Apr
29
2022
FDA Issues Draft Action Levels for Lead in Juice Keller and Heckman LLP
Apr
29
2022
International Cooperation under China’s Proposed Implementing Rules for Human Genetic Resources Management Sheppard, Mullin, Richter & Hampton LLP
Apr
29
2022
How Pharmacies Can Defend Against PBM Audits Oberheiden P.C.
Apr
29
2022
New Guidance for Management of Biological Foodborne Outbreaks, and Identification of CCPs Keller and Heckman LLP
Apr
28
2022
FDA Updates FSVP Guidance on UFI Keller and Heckman LLP
Apr
28
2022
India: Another Booming Market for Alternative Proteins in Asia Keller and Heckman LLP
Apr
28
2022
The Metaverse: Alcohol Beverage Industry’s Next Marketing Frontier? ArentFox Schiff LLP
Apr
27
2022
Baby Food Lawsuit Dismissed as “Simply Speculative” Keller and Heckman LLP
Apr
27
2022
California Bill Proposes to Prohibit Employment Discrimination Against Marijuana Users Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
26
2022
Medicaid Best Price 101: A Review of Medicaid Best Price Policy and New CMS Guidance on Medicaid Best Price Reporting for Value Based Purchasing Arrangements Mintz
Apr
26
2022
What Municipalities Need to Know in 2022: Newly Signed Pennsylvania Legislation Strassburger McKenna Gutnick & Gefsky
Apr
26
2022
What’s Brewing at Starbucks? Labor Law Litigation Over Employee Terminations Barnes & Thornburg LLP
Apr
26
2022
FDA Urged to Make Changes to its Food Recall Activities Keller and Heckman LLP
Apr
25
2022
Morningstar Farms “Veggie” Product Labeling Complaint Dismissed Keller and Heckman LLP
Apr
25
2022
Navigating the Cannabis Fog: Litigation Ensues Over Legality of Delta-8 and Delta-10 Bradley Arant Boult Cummings LLP
Apr
25
2022
FDA Publishes Final Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials Bergeson & Campbell, P.C.
Apr
22
2022
With Proposal to Cap Drug Price Increases, Massachusetts Once Again Takes Center Stage in the Drug Pricing Debate Mintz
Apr
22
2022
FDA Releases Draft Guidance on NAC Enforcement Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins